At 52, he was in the best shape of his life. He lifted weights four days a week, ate clean by most people’s standards, hadn’t smoked in 15 years. His cholesterol came back at 225.
His doctor put him on a statin.
Six months later he was fatigued in a way that had nothing to do with his training. His libido had dropped. He felt mentally sluggish. He told his doctor. The doctor said it was probably just aging.
He was 52.
When he connected with a functional medicine provider and ran a full panel, the picture became clearer. His insulin markers were fine. His cardiac calcium score was zero. No plaque. Hormones were in good shape. His cholesterol was slightly elevated but not causing any of the downstream damage that would make it a clinical concern.
What was causing his fatigue, low libido, and brain fog was the statin itself. Specifically, its suppression of CoQ10 and its interference with sex hormone production.
The System That Creates Over-Prescribing
Statins are one of the most widely prescribed medications in the world. They have an important role in specific clinical contexts. A patient who has had a heart attack or stroke, who has confirmed plaque formation, high inflammation, and insulin resistance, is a strong candidate for statin therapy.
But the prescription threshold in conventional medicine is not built on individual risk assessment. It’s built on population guidelines implemented through insurance and legal frameworks.
Here is how the system actually works: if a patient’s total cholesterol exceeds 200, most insurance-driven practices require statin prescribing to comply with clinical guidelines. Providers who don’t comply face financial penalties. Some practices reduce pay by $50 to $100 per patient for every patient above a certain threshold who is not on a statin or diabetes medication.
The legal exposure amplifies this. If a patient is not medicated and has a cardiovascular event, the liability falls on the provider for not following guidelines. The guidelines exist partly to protect providers legally, not entirely to serve individual patient outcomes.
This creates a system where statins are prescribed to meet a metric. Not because the individual patient’s cardiovascular risk has been carefully assessed. Not because the benefits outweigh the risks for that specific person. Because the number crossed a threshold.
What Statins Block (and Why That Matters After 40)
Understanding why statins produce the side effects they do requires understanding what they block.
Statins reduce cholesterol synthesis in the liver. As a consequence, they also block the production of CoQ10 (coenzyme Q10). CoQ10 is a molecule essential for cellular energy production, muscle function, and cardiac performance. It’s how your cells generate the energy they need to do their jobs.
When CoQ10 is suppressed, the result is fatigue that doesn’t respond to rest, exercise intolerance, muscle weakness, and brain fog. These are textbook statin side effects that many patients experience and many providers attribute to aging rather than the medication.
Cholesterol is also the building block for sex hormones. Testosterone, estrogen, progesterone, cortisol. All of them are synthesized from cholesterol. When a high-dose statin drives cholesterol very low, hormone production drops with it.
For men, this often means declining testosterone. Low libido, reduced motivation, fatigue, mental sluggishness, difficulty building or maintaining muscle. All predictable downstream effects of suppressed cholesterol in a hormonal system that depends on it.
For women, the same pathway affects estrogen and progesterone. This matters especially in the perimenopause and post-menopause years, when these hormones are already in transition. Adding a statin to a system that’s already managing hormonal change compounds the problem.
And statins may worsen insulin resistance, which is one of the primary root causes of elevated cholesterol in the first place. The medication prescribed to address the symptom may make the underlying cause worse.
The Cardiovascular Risk Picture That Actually Matters
Total cholesterol above 200 is not, by itself, a meaningful cardiovascular risk indicator.
Recent large-scale research, studies involving hundreds of thousands of participants, has shown that lower cholesterol correlates with higher rates of cardiovascular disease, stroke, dementia, and death. This data contradicts decades of clinical messaging that the lower the cholesterol, the better.
What does predict cardiovascular risk more accurately: insulin resistance, inflammation, and whether LDL is oxidized and causing actual plaque formation.
VLDL (very low-density lipoprotein) is more associated with plaque formation than LDL. Apolipoprotein B is the molecule actually responsible for plaque. Lipoprotein(a) has a stronger association with cardiovascular events than total cholesterol or LDL alone.
None of these are on a standard lipid panel.
A cardiac calcium score CT scan shows whether plaque is actually forming. A calcium score of zero means no plaque, regardless of what the cholesterol number is. A fit 52-year-old with a cholesterol of 225 and a calcium score of zero has no documented plaque. The case for a statin in that patient is unclear at best.
Inflammation of the endothelium, the single-cell layer that lines blood vessels, is what allows cholesterol particles to begin sticking and forming plaque. The root drivers of that inflammation are ultra-processed food, seed oils, blood sugar instability, and environmental toxin exposure. Addressing those factors addresses the actual mechanism.
After 40: Why the Risk-Benefit Calculation Shifts
The stakes of getting this wrong increase with age, and they run in both directions.
As people age past 40, the hormonal systems that depend on cholesterol become increasingly important. Testosterone production in men declines gradually starting in the late 30s. Estrogen and progesterone begin their transitions toward perimenopause in women, often starting in the early to mid-40s. Both of these transitions are sensitive to anything that suppresses the cholesterol those hormones need.
Muscle mass becomes harder to maintain after 40, and muscle health depends significantly on testosterone. Suppressing testosterone through statin-driven cholesterol reduction in a 50-year-old man who is actively trying to maintain his health and strength works directly against the goal.
CoQ10 depletion hits harder after 40 as well. Cellular energy production naturally becomes less efficient with age. Blocking CoQ10 on top of that natural decline produces symptoms that feel much more severe than they might in a younger patient.
At the same time, the patients who genuinely benefit from statins, those with documented cardiovascular disease, confirmed plaque formation, significant insulin resistance, and high inflammatory markers, also tend to be in older age groups. The medication has appropriate uses. The problem is the wide net being cast.
What Getting Off a Statin Actually Looks Like
Stopping a statin is not something to do on your own or suddenly. It requires working with a provider to assess actual cardiovascular risk, address the underlying metabolic factors that may have justified the prescription in the first place, and monitor the transition.
What makes it possible is correcting the root causes. Addressing insulin resistance through dietary change, lifestyle intervention, and hormone optimization. Reducing inflammation through removing processed food, seed oils, and other inflammatory drivers. Using more comprehensive cardiac risk assessment (expanded lipid panels, calcium scoring) rather than relying on a total cholesterol number alone.
Patients who do this work, who lose significant weight, normalize their A1C, and address hormonal imbalances, often find their cholesterol numbers improve without a statin. The elevated cholesterol was a downstream effect of the metabolic dysfunction. Treating the dysfunction treated the number.
Reversing insulin resistance is possible. Conventional medicine frequently tells patients that type 2 diabetes is not reversible. Functional medicine has demonstrated repeatedly that it can be, through the kind of comprehensive root-cause work that conventional five-minute visits don’t have the time or framework to deliver.
The Questions Worth Asking
If you’re over 40 and on a statin, or if your doctor is recommending one, several questions are worth raising before deciding:
What is your cardiac calcium score? A score of zero means no plaque is forming, regardless of cholesterol levels.
Has your insulin resistance been assessed? Fasting insulin, hemoglobin A1C, VLDL, and inflammatory markers paint a more accurate picture of cardiovascular risk than total cholesterol alone.
Have your sex hormones been checked? If testosterone, estrogen, or progesterone are already marginal, reducing cholesterol further will suppress them more.
What are you experiencing since starting the statin? Fatigue, muscle weakness, brain fog, and low libido that appeared or worsened after starting the medication are worth connecting to it before accepting them as inevitable aging.
Are there lifestyle and metabolic changes that could address the root cause? Dietary change, insulin resistance reversal, and hormonal optimization sometimes resolve the cholesterol picture without medication.
These are not contrarian questions. They’re reasonable due diligence for a medication that has real side effects and is sometimes prescribed to meet a metric rather than to address a documented risk.
You deserve a complete risk assessment, not just a number crossed against a threshold.
About the Author: This article was written by the clinical education team at Med Matrix, a functional medicine clinic in South Portland, Maine. Med Matrix serves over 3,000 patients with a provider team that specializes in root-cause testing, hormone optimization, and personalized treatment plans.
